Catalyst Wire Dossier Catalyst Wire Dossier

SIGNIFOR

PASIREOTIDE · Recordati Rare Diseases, Inc.
Drug timelines are a Plus or Pro feature.

18 regulatory and trial events tracked for SIGNIFOR, covering 2012-12-14 to 2026-08-05. Get the full timeline:

Most recent: EMA Authorised: Signifor (pasireotide) — Recordati Rare Diseases

See pricing